Lobbying

Finkelstein & Krinsk's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Torts.

Finkelstein & Krinsk

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Finkelstein & Krinsk lobbying by quarter
Finkelstein & Krinsk lobbying by quarter
QuarterAmountReports
Q4 2022$60K1
Q1 2023$60K1
Q2 2023$60K1
Q3 2023$60K1
Q4 2023$60K1
Q1 2024$01
Q2 2024$01
Q3 2024$01
Q4 2024$01
Q1 2025$01
Q2 2025$10K1
Q3 2025$01
Q4 2025$01
Q1 2026$01
Q2 2026$01
Q3 2026$00

By issue

  • Torts$310K · 15 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Consumer Product Safety Commission (CPSC)15 reports
  • Food & Drug Administration (FDA)15 reports
  • HOUSE OF REPRESENTATIVES15 reports
  • SENATE15 reports

Firms it paid

Firm
Sconset Strategies$310K15 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
07/22for Q2Sconset StrategiesUnder $5,000
04/20for Q1Sconset StrategiesUnder $5,000
01/20for Q4 2025Sconset StrategiesUnder $5,000
25/10/20for Q3 2025Sconset StrategiesUnder $5,000
25/07/21for Q2 2025Sconset Strategies$10K
25/04/21for Q1 2025Sconset StrategiesUnder $5,000
25/01/21for Q4 2024Sconset StrategiesUnder $5,000
24/10/21for Q3 2024Sconset StrategiesUnder $5,000
24/07/22for Q2 2024Sconset StrategiesUnder $5,000
24/04/22for Q1 2024Sconset StrategiesUnder $5,000
24/01/24for Q4 2023Sconset Strategies$60K
23/10/20for Q3 2023Sconset Strategies$60K
23/07/20for Q2 2023Sconset Strategies$60K
23/04/20for Q1 2023Sconset Strategies$60K
23/01/20for Q4 2022Sconset Strategies$60K